SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-03-001535
Filing Date
2003-11-10
Accepted
2003-11-10 17:18:50
Documents
12
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PERIOD ENDED 9-30-2003 a94247e10vq.htm 10-Q 213583
3 EXHIBIT 10.39 a94247exv10w39.txt EX-10.39 10234
4 EXHIBIT 10.40 a94247exv10w40.txt EX-10.40 6719
5 EXHIBIT 10.44 a94247exv10w44.txt EX-10.44 31485
6 EXHIBIT 10.45 a94247exv10w45.txt EX-10.45 37549
7 EXHIBIT 10.46 a94247exv10w46.txt EX-10.46 31559
8 EXHIBIT 10.47 a94247exv10w47.txt EX-10.47 37807
9 EXHIBIT 10.48 a94247exv10w48.txt EX-10.48 31297
10 EXHIBIT 10.49 a94247exv10w49.txt EX-10.49 37547
11 EXHIBIT 31.1 a94247exv31w1.txt EX-31.1 4811
12 EXHIBIT 31.2 a94247exv31w2.txt EX-31.2 4885
13 EXHIBIT 32.0 a94247exv32w0.txt EX-32.0 2132
  Complete submission text file 0000936392-03-001535.txt   452445
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 03989486
SIC: 2836 Biological Products, (No Diagnostic Substances)